SecBot SecBot
SC 13G/A ·Filed Nov 3, 2026

PYXS

Pyxis Oncology, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed13d 18h ago SEC0001390202-26-000019
Passive stake amendment
Actionable Insight ▼ Bearish

A major passive holder has shed roughly 85% of its position in 32 days, now just above the 5% reporting threshold. Monitor for further sales that could bring the stake below 5%, which would remove a large overhang but also signal continued lack of conviction.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$1.64
T+0 close · Nov 3, 2026 · via day close
Latest settled
−0.61%
T+5 · $1.63 · next T+20 in 15d
Vs SPY
−0.02%
α at T+5
Latest observation
−0.54%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $1.64entry
  2. T+1 · 13d ago +1.22%α −0.43% · $1.66
  3. T+5 · 7d ago −0.61%α −0.02% · $1.63
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Laurion Capital Management LP filed an amended Schedule 13G disclosing a reduced passive stake of 4,300,888 shares (5.16%) in Pyxis Oncology as of September 30, 2026, down from 27,988,714 shares (17.5%) reported just 32 days earlier. This represents a substantial reduction in a previously large passive position.

Key Financial Metrics

Stake
5.16%
Investor
Laurion Capital Management LP
Investor Type
hedge fund

Key Facts

  • Laurion Capital Management LP disclosed beneficial ownership of 4,300,888 shares of Pyxis Oncology common stock, representing 5.16% of shares outstanding as of September 30, 2026.
  • This is a significant reduction from the 27,988,714 shares (17.5%) reported in the prior SC 13G/A filed on October 2, 2026.
  • The filing is made under Rule 13d-1(b), confirming a passive investment intent with no control purpose.
  • The stake is held through Laurion Capital Master Fund Ltd. and other funds managed by Laurion Capital.

Financial Impact

Laurion Capital reduced its stake from approximately 27.99 million shares to 4.30 million shares, a reduction of roughly 23.69 million shares (about 84.6% of the prior position). Based on the current market cap of $226M, the sold stake was worth approximately $122M at the time of sale.

ownership_percentageshare_count

Risk Factors

  • Laurion Capital may continue to reduce its position, potentially selling below the 5% threshold and ceasing to file 13G amendments.
  • The rapid reduction by a sophisticated hedge fund could indicate negative non-public information or deteriorating fundamentals.
  • The remaining 5.16% stake still represents a meaningful overhang if the fund continues to exit.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001390202-26-000019
Document: 0001390202-26-000019-index.html0001390202-26-000019
Document: 0001390202-26-000019.txt0001390202-26-000019

Track record

25 reports on PYXS

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +42.94% at T+60 after the Apr 17, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry $1.43 Now $1.41 −1.32% settles Dec 16
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.43 Now $1.41 −1.40% settles Dec 16
  3. Nov 16, 2026today SC 13G Neutral 4/10 Entry $1.55 Now $1.41 −9.14% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 Entry $1.61 Now $1.41 −12.42% settles Dec 4
  5. Nov 3, 202613d ago SC 13G/A Bearish 5/10 Viewing Entry $1.64 Now $1.41 +14.02% settles Dec 2
  6. Oct 27, 202620d ago Press Release Neutral 4/10 Entry $1.84 Now $1.41 −23.37% settles Nov 24
  7. Oct 21, 202626d ago DEF 14A Bearish 6/10 Entry $1.71 Now $1.41 +17.54% settles Nov 19
  8. Oct 9, 20265w ago SC 13G/A Neutral 4/10 Entry $2.03 to $1.66 Now $1.41 −30.54% ▼ −18.23% −12.67% vs SPY
  9. Oct 2, 20266w ago SC 13G/A Neutral 4/10 Entry $2.14 to $1.81 Now $1.41 −34.11% ▼ −15.42% −13.61% vs SPY
  10. Oct 2, 20266w ago Press Release Bearish 7/10 Entry $2.14 to $1.81 Now $1.41 +34.11% ▲ +15.42% +13.61% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 6h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026